#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA669305	B	Inhibitory activity towards dihydrofolate reductase in L1210 murine leukemia cell lines		4	ALA1122810	cell-based format	Scientific Literature
2.	ALA669624	B	Activity relative to methotrexate for inhibition of Dihydrofolate reductase from L1210 murine leukemia cell lines		3	ALA1122810	cell-based format	Scientific Literature
3.	ALA690542	F	Growth inhibition of H35 cell lines	Rattus norvegicus	4	ALA1122810	cell-based format	Scientific Literature
4.	ALA690543	F	Cytotoxic activity with respect to methotrexate	Rattus norvegicus	4	ALA1122810	cell-based format	Scientific Literature
5.	ALA688480	F	Growth inhibition of H35R0.3 cell lines	Rattus norvegicus	4	ALA1122810	cell-based format	Scientific Literature
6.	ALA688481	F	Cytotoxic activity with respect to methotrexate	Rattus norvegicus	3	ALA1122810	cell-based format	Scientific Literature
7.	ALA707181	F	Cytotoxic activity with respect to methotrexate	Mus musculus	3	ALA1122810	cell-based format	Scientific Literature
8.	ALA706225	F	Growth inhibition of L1210 cell lines	Mus musculus	4	ALA1122810	cell-based format	Scientific Literature
9.	ALA719122	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day 1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 10 mg/kg	Mus musculus	3	ALA1122810	organism-based format	Scientific Literature
10.	ALA719123	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day 1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 20 mg/kg	Mus musculus	3	ALA1122810	organism-based format	Scientific Literature
11.	ALA719124	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day 1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 40 mg/kg	Mus musculus	3	ALA1122810	organism-based format	Scientific Literature
12.	ALA721397	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 10 mg/kg	Mus musculus	3	ALA1122810	organism-based format	Scientific Literature
13.	ALA721398	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 20 mg/kg	Mus musculus	3	ALA1122810	organism-based format	Scientific Literature
14.	ALA721399	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 40 mg/kg	Mus musculus	3	ALA1122810	organism-based format	Scientific Literature
15.	ALA730341	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day 1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 10 mg/kg; T =11; C=9	Mus musculus	2	ALA1122810	organism-based format	Scientific Literature
16.	ALA729384	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day 1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 20 mg/kg; T =13; C=9	Mus musculus	1	ALA1122810	organism-based format	Scientific Literature
17.	ALA729387	F	Inoculation of 10 e5 L1210 cells, ip, on day 0, & treatment was started on day 1 with the administration of the compound, ip, in groups of five B6D2F1J male mice at dose 40 mg/kg; T =15; C=9	Mus musculus	1	ALA1122810	organism-based format	Scientific Literature